Brennan Aoife
President and CEO
Brennan Aoife has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Brennan Aoife is listed as President and CEO at Climb Bio, Inc. Inside the rolling window, Brennan Aoife reported no open-market purchases and 1 open-market sale totaling $407K in CLYM.
Companies traded
Other insiders at CLYM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$407K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brennan Aoife made?
Brennan Aoife has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Brennan Aoife trade?
Brennan Aoife has filed SEC Form 4 disclosures for 1 company, including CLYM.
When was Brennan Aoife's most recent SEC Form 4 filing?
Brennan Aoife's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Brennan Aoife's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brennan Aoife is listed as President and CEO.
What is Brennan Aoife's total buy and sell value in the current window?
Inside the rolling retention window, Brennan Aoife bought $0 and sold $407K based on SEC Form 4 filings.
What was Brennan Aoife's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,902 CLYM shares on 2026-06-29, worth $407K, per SEC Form 4 filings.